Efficacy and safety of adalimumab (HUMIRA®) in European clinical practice:: The react trial

被引：0
|
作者：
Burmester, GR
Sáez, IM
Malaise, M
da Silva, JC
Webber, DG
Kupper, H
机构：
[1] Humboldt Univ, Univ Klinikum Charite, Berlin, Germany
[2] HGU Gregorio Maranon, Madrid, Spain
[3] CHU, Liege, Belgium
[4] Hosp Garcia Orta, Serv Reumatol, Almada, Portugal
[5] Abbott GmbH & Co KG, Immunosci, Ludwigshafen, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：90 / 90
页数：1
相关论文
共 50 条
  • [41] Clinical remission and good clinical responses in patients with psoriatic arthritis (PsA) treated with adalimumab (HUMIRA®):: Results of the STEREO trial
    Van den Bosch, Filip
    Manger, Bernhard
    Goupille, Philippe
    Kron, Martina
    Kary, Sonja
    Kupper, Hartmut
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S576 - S576
  • [42] Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa The SHARPS Randomized Clinical Trial
    Bechara, Falk G.
    Podda, Maurizio
    Prens, Errol P.
    Horvath, Barbara
    Giamarellos-Bourboulis, Evangelos J.
    Alavi, Afsaneh
    Szepietowski, Jacek C.
    Kirby, Joslyn
    Geng, Ziqian
    Jean, Christine
    Jemec, Gregor B. E.
    Zouboulis, Christos C.
    JAMA SURGERY, 2021, 156 (11) : 1001 - 1009
  • [43] Efficacy of adalimumab for Crohn's disease in real clinical practice
    Knyazev, O. V.
    Kagramanova, A. V.
    Ruchkina, I. N.
    Fadeeva, N. A.
    Lishchinskaya, A. A.
    Boldyreva, O. N.
    Zhulina, E. Yu.
    Shcherbakov, P. L.
    Orlova, N. V.
    Kirova, M. V.
    Parfenov, A. I.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (02) : 20 - 27
  • [44] Efficacy of 80 mg/week dose of adalimumab (Humira) in treatment of hidradenitis suppurativa
    Saad, Saadeddine S.
    Haley, Christopher
    Hatfield, Jess
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB51 - AB51
  • [45] Safety and efficacy of idarucizumab in clinical practice
    Wang, Josh J.
    Villeneuve, Eric
    Dupont, Celine
    Gosselin, Sophie
    CLINICAL TOXICOLOGY, 2017, 55 (07) : 703 - 704
  • [46] Efficacy and safety of Fingolimod in clinical practice
    Regal, A. R.
    Midaglia, L.
    Costa Arpin, E.
    Rodriguez Rodriguez, M.
    Pato Pato, A.
    Lopez Real, A. M.
    Llaneza Gonzalez, M. A.
    Garcia Estevez, D. A.
    Moreno Munoz, M. J.
    Escriche Jaime, D.
    Aguado Valcarcel, M. L.
    Munoz Garcia, D.
    Prieto Gonzalez, J. M.
    Lorenzo Gonzalez, J. R.
    Amigo Jorrin, M. C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 211 - 211
  • [47] The ARMADA trial:: Sustained efficacy and long-term safety of adalimumab (humira®) plus methotrexate over 3 years in patients with long-standing rheumatoid arthritis
    Weinblatt, ME
    Keystone, EC
    Furst, DE
    Kavanaugh, AF
    Spencer-Green, GT
    Mydler, T
    Segurado, OG
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 295 - 295
  • [48] Efficacy and safety of adalimumab (Humira®) is maintained during long-term treatment of rheumatoid arthritis within a large cohort of patients in normal clinical practice:: Realise-a post-marketing observational study
    Burmester, G. R.
    Cerinic, M. Matucci
    Goupille, P.
    Blasco, F. Navarro
    Oezer, U.
    Jaeger, M.
    Kupper, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 180 - 181
  • [49] Use, Safety and Efficacy of Zrc 3197, a Biosimilar Candidate for Reference Adalimumab (Humira) from a Tertiary Pediatric Rheumatology Centre in India
    Agarwal, Manjari
    Shivpuri, Abhay
    Mittal, Sumidha
    Khosla, Amit
    Sawhney, Sujata
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [50] The armada trial:: Sustained efficacy after dose reduction of concomitant methotrexate and/or corticosteroids in patients with rheumatoid arthritis treated with adalimumab (HUMIRA®)
    Weinblatt, ME
    Keystone, EC
    Furst, DE
    Kavanaugh, AF
    Spencer-Green, GT
    Segurado, OG
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 436 - 436
12345